186 related articles for article (PubMed ID: 24423299)
1. Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy.
Weissgerber TL; Rajakumar A; Myerski AC; Edmunds LR; Powers RW; Roberts JM; Gandley RE; Hubel CA
J Clin Endocrinol Metab; 2014 Mar; 99(3):978-87. PubMed ID: 24423299
[TBL] [Abstract][Full Text] [Related]
2. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
[TBL] [Abstract][Full Text] [Related]
4. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.
Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293
[TBL] [Abstract][Full Text] [Related]
5. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
[TBL] [Abstract][Full Text] [Related]
6. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
7. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
[TBL] [Abstract][Full Text] [Related]
9. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
Bdolah Y; Elchalal U; Natanson-Yaron S; Yechiam H; Bdolah-Abram T; Greenfield C; Goldman-Wohl D; Milwidsky A; Rana S; Karumanchi SA; Yagel S; Hochner-Celnikier D
Hypertens Pregnancy; 2014 May; 33(2):250-9. PubMed ID: 24304210
[TBL] [Abstract][Full Text] [Related]
10. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
[TBL] [Abstract][Full Text] [Related]
11. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
Bian Z; Shixia C; Duan T
PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
[TBL] [Abstract][Full Text] [Related]
12. [THE ROLE OF ANGIOGENIC FACTORS IN THE DIAGNOSTICS OF PREGNANCY COMPLICATED WITH PREECLAMPSIA].
Tagiyeva I; Aliyeva S; Bagirova S; Shamsadinskaya N; Agaeva K
Georgian Med News; 2017; (268-269):35-38. PubMed ID: 28820409
[TBL] [Abstract][Full Text] [Related]
13. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
14. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors for the prediction of preeclampsia in high-risk women.
Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
[TBL] [Abstract][Full Text] [Related]
16. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
17. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
18. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
19. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period.
Petrozella L; Mahendroo M; Timmons B; Roberts S; McIntire D; Alexander JM
Am J Obstet Gynecol; 2012 Aug; 207(2):140.e20-6. PubMed ID: 22840727
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
